1. Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Issue 1 (7th November 2020) Authors: Corral, Juan E; Kwon, Joshua Y; Caldera, Freddy; Pungpapong, Surakit; Spaulding, Aaron C; Borah, Bijan J; Moriarty, James P; Farraye, Francis A Journal: Crohn's & colitis 360 Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗